Phase II: Adaptive De-escalation of Radiation Therapy Dose In Favorable Risk HPV-Positive Oropharyngeal Carcinoma (ART)

Brief description of study

The main goal of this study is to determine if deescalating chemoradiation treatment based on early tumor shrinkage at mid-treatment can result in similar cancer cure rates as standard treatment but fewer side effects and better quality of life.


Clinical Study Identifier: s17-00330
ClinicalTrials.gov Identifier: NCT03215719


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.